The LNS is pleased to announce the renewal and extension of the scope of the ISO 15189 accreditation of its department of medical biology by the Office Luxembourgeois d’Accréditation et de Surveillance (OLAS).
Since 2017, the department has maintained its accreditation in many areas of medical biology, corresponding to more than 40 accredited parameters of general biochemistry and specialised hormonology, such as 1,25 di-hydroxy-vitamin D, IGF-1 growth hormone on automated techniques, catecholamines, or vitamins (B1, B6) measured by high performance liquid chromatography, 17-hydroxy-progesterone, TSH or immuno-reactive trypsin included in the national neonatal screening programme. In addition, medical toxicology analyses, such as blood tests for anti-epileptics and neuroleptics using mass spectrometry, urinary drug screening using immunoassay or urinary iodine using ICP-MS.
The department has just reached a new step with the extension of this accreditation to new separative techniques concerning the determination of vitamins A and E by UPLC-UV chromatography, urinary porphyrins by UPLC-Fluo chromatography, CDT (marker of chronic alcoholism) by capillary electrophoresis, and the quantitative determination of THC-COOH (metabolite of cannabis) in urine by LC-MSMS.
Clément Kebbabi, the department’s quality referent, explains: “Quality assurance is the cornerstone of continuous improvement: this accreditation renewal bears witness to the quality of our expertise and our commitment to always do better for our patients.”
The ISO 15189 standard is an international reference that formally recognizes the technical and organizational competence of clinical biology laboratories that comply with it.
The LNS congratulates and thanks the entire team of the medical biology department for this new accreditation, which once again underlines that excellence is at the heart of the LNS value system.